Cargando…
Inflammatory and anti-inflammatory markers in plasma: from late pregnancy to early postpartum
During pregnancy, the woman’s body undergoes tremendous changes in immune system adaptation. The immunological shifts that occur in pregnancy can partially be explained by alterations in hormonal levels. Furthermore, during pregnancy, many autoimmune diseases go into remission, only to flare again i...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372606/ https://www.ncbi.nlm.nih.gov/pubmed/30755659 http://dx.doi.org/10.1038/s41598-018-38304-w |
_version_ | 1783394782420140032 |
---|---|
author | Bränn, Emma Edvinsson, Åsa Rostedt Punga, Anna Sundström-Poromaa, Inger Skalkidou, Alkistis |
author_facet | Bränn, Emma Edvinsson, Åsa Rostedt Punga, Anna Sundström-Poromaa, Inger Skalkidou, Alkistis |
author_sort | Bränn, Emma |
collection | PubMed |
description | During pregnancy, the woman’s body undergoes tremendous changes in immune system adaptation. The immunological shifts that occur in pregnancy can partially be explained by alterations in hormonal levels. Furthermore, during pregnancy, many autoimmune diseases go into remission, only to flare again in the early postpartum period. Given these important changes in the clinical course of a number of autoimmune disorders, surprisingly little has been done to investigate the inflammatory profile changes across pregnancy and the postpartum period. Thus, the aim of this study was to describe how inflammatory and anti-inflammatory markers change from late pregnancy to the early postpartum period, using a multiplexed assay consisting of both well-known as well as exploratory proteins. Two-hundred-and-ninety women were included in this study and donated a total of 312 blood samples; 198 in late pregnancy (~gw38) and 114 in the postpartum period (~w8). The plasma blood samples were analyzed for 92 immune system related protein markers using Proseek Multiplex Inflammation I panel, a high-sensitivity assay based on proximity extension assay technology. Fifty-six inflammatory and anti-inflammatory markers were significantly different between pregnancy and the postpartum, of which 50 survived corrections for multiple comparisons. Out of these 50 markers, 41 decreased from pregnancy to postpartum, while the remaining 9 increased in the postpartum period. The top five markers with the greatest decrease in the postpartum period were Leukemia inhibitory factor receptor (LIF-R), Latency-associated peptide Transforming growth factor beta-1 (LAP TGF-beta-1), C-C motif chemokine 28 (CCL28), Oncostatin M (OSM) and Fibroblast growth factor 21 (FGF21). Top three markers that increased in the postpartum period were Tumor necrosis factor ligand superfamily member 11 (TRANCE), Tumor necrosis factor ligand superfamily member 12 (TWEAK), and C-C motif chemokine/Eotaxin (CCL11). This study revealed that the majority of the markers decreased from pregnancy to postpartum, and only a few increased. Several of the top proteins that were higher in pregnancy than postpartum have anti-inflammatory and immune modulatory properties promoting pregnancy progress. These results clearly reflect the tremendous change in the immune system in the pregnancy to postpartum transition. |
format | Online Article Text |
id | pubmed-6372606 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-63726062019-02-19 Inflammatory and anti-inflammatory markers in plasma: from late pregnancy to early postpartum Bränn, Emma Edvinsson, Åsa Rostedt Punga, Anna Sundström-Poromaa, Inger Skalkidou, Alkistis Sci Rep Article During pregnancy, the woman’s body undergoes tremendous changes in immune system adaptation. The immunological shifts that occur in pregnancy can partially be explained by alterations in hormonal levels. Furthermore, during pregnancy, many autoimmune diseases go into remission, only to flare again in the early postpartum period. Given these important changes in the clinical course of a number of autoimmune disorders, surprisingly little has been done to investigate the inflammatory profile changes across pregnancy and the postpartum period. Thus, the aim of this study was to describe how inflammatory and anti-inflammatory markers change from late pregnancy to the early postpartum period, using a multiplexed assay consisting of both well-known as well as exploratory proteins. Two-hundred-and-ninety women were included in this study and donated a total of 312 blood samples; 198 in late pregnancy (~gw38) and 114 in the postpartum period (~w8). The plasma blood samples were analyzed for 92 immune system related protein markers using Proseek Multiplex Inflammation I panel, a high-sensitivity assay based on proximity extension assay technology. Fifty-six inflammatory and anti-inflammatory markers were significantly different between pregnancy and the postpartum, of which 50 survived corrections for multiple comparisons. Out of these 50 markers, 41 decreased from pregnancy to postpartum, while the remaining 9 increased in the postpartum period. The top five markers with the greatest decrease in the postpartum period were Leukemia inhibitory factor receptor (LIF-R), Latency-associated peptide Transforming growth factor beta-1 (LAP TGF-beta-1), C-C motif chemokine 28 (CCL28), Oncostatin M (OSM) and Fibroblast growth factor 21 (FGF21). Top three markers that increased in the postpartum period were Tumor necrosis factor ligand superfamily member 11 (TRANCE), Tumor necrosis factor ligand superfamily member 12 (TWEAK), and C-C motif chemokine/Eotaxin (CCL11). This study revealed that the majority of the markers decreased from pregnancy to postpartum, and only a few increased. Several of the top proteins that were higher in pregnancy than postpartum have anti-inflammatory and immune modulatory properties promoting pregnancy progress. These results clearly reflect the tremendous change in the immune system in the pregnancy to postpartum transition. Nature Publishing Group UK 2019-02-12 /pmc/articles/PMC6372606/ /pubmed/30755659 http://dx.doi.org/10.1038/s41598-018-38304-w Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Bränn, Emma Edvinsson, Åsa Rostedt Punga, Anna Sundström-Poromaa, Inger Skalkidou, Alkistis Inflammatory and anti-inflammatory markers in plasma: from late pregnancy to early postpartum |
title | Inflammatory and anti-inflammatory markers in plasma: from late pregnancy to early postpartum |
title_full | Inflammatory and anti-inflammatory markers in plasma: from late pregnancy to early postpartum |
title_fullStr | Inflammatory and anti-inflammatory markers in plasma: from late pregnancy to early postpartum |
title_full_unstemmed | Inflammatory and anti-inflammatory markers in plasma: from late pregnancy to early postpartum |
title_short | Inflammatory and anti-inflammatory markers in plasma: from late pregnancy to early postpartum |
title_sort | inflammatory and anti-inflammatory markers in plasma: from late pregnancy to early postpartum |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372606/ https://www.ncbi.nlm.nih.gov/pubmed/30755659 http://dx.doi.org/10.1038/s41598-018-38304-w |
work_keys_str_mv | AT brannemma inflammatoryandantiinflammatorymarkersinplasmafromlatepregnancytoearlypostpartum AT edvinssonasa inflammatoryandantiinflammatorymarkersinplasmafromlatepregnancytoearlypostpartum AT rostedtpungaanna inflammatoryandantiinflammatorymarkersinplasmafromlatepregnancytoearlypostpartum AT sundstromporomaainger inflammatoryandantiinflammatorymarkersinplasmafromlatepregnancytoearlypostpartum AT skalkidoualkistis inflammatoryandantiinflammatorymarkersinplasmafromlatepregnancytoearlypostpartum |